Cognitive
10
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
The Acute Effects of Onnit Alpha Brain on Cognition and Mood States
Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients
Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level
Nurse-Led Elderly Sleep Intervention
Cognitive Health Awareness Program in Surgical Patients
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
To Evaluate the Efficacy of Lutemax 2020 on Vision and Cognitive Performance in Health Children.
Multimodal Brain Function in Migraine Patients With Patent Foramen Ovale
A Predictive Model for Postoperative Delirium in Kidney Transplant Patients
Acute Nerve Stimulation For Enhancing Human and Cognitive Performance